BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 32003672)

  • 1. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
    Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
    Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
    Ji Y; Wang D; Zhang B; Lu H
    J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
    Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
    J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
    Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
    Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
    Jiang Y; Zhang Y; Su L
    Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-181a protects against pericyte apoptosis via directly targeting FOXO1: implication for ameliorated cognitive deficits in APP/PS1 mice.
    Wu Q; Yuan X; Bai J; Han R; Li Z; Zhang H; Xiu R
    Aging (Albany NY); 2019 Aug; 11(16):6120-6133. PubMed ID: 31467256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer's disease mice via regulation of HMGB1/NF-κB signaling.
    Shao P
    Brain Res; 2021 Sep; 1766():147511. PubMed ID: 33957091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
    Li Q; Li X; Wang L; Zhang Y; Chen L
    J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease.
    Liu Z; Wang C; Wang X; Xu S
    Cell Physiol Biochem; 2015; 37(1):321-30. PubMed ID: 26316079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
    Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
    Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice.
    Fu CH; Han XY; Tong L; Nie PY; Hu YD; Ji LL
    Behav Brain Res; 2021 Sep; 414():113485. PubMed ID: 34302879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance.
    Guo XD; Sun GL; Zhou TT; Xu X; Zhu ZY; Rukachaisirikul V; Hu LH; Shen X
    Acta Pharmacol Sin; 2016 Sep; 37(10):1281-1297. PubMed ID: 27569389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
    Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
    Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
    Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
    Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy.
    Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ
    Theranostics; 2021; 11(5):2395-2409. PubMed ID: 33500732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.